Sensitivity to fungi is a common clinical problem. Although many commercial extracts for diagnosis and treatment of fungal sensitivity are available, there is a lack of standardized materials. New research into the isolation and purification of fungal allergens may improve upon this situation. Controlled immunotherapy trials with fungal extracts have identified selected populations who may benefit from this type of therapy.